These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
19 related articles for article (PubMed ID: 1359571)
1. Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence. Zhang C; Fang Y; Li M Pharmacol Biochem Behav; 2011 Mar; 98(1):155-60. PubMed ID: 21194545 [TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy. Shlik J; Vasar E; Bradwejn J CNS Drugs; 1997 Aug; 8(2):134-52. PubMed ID: 23338219 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Kinon BJ; Lieberman JA Psychopharmacology (Berl); 1996 Mar; 124(1-2):2-34. PubMed ID: 8935797 [TBL] [Abstract][Full Text] [Related]
4. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs. Blackburn JR; Phillips AG Psychopharmacology (Berl); 1989; 98(4):453-9. PubMed ID: 2570431 [TBL] [Abstract][Full Text] [Related]
5. A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802. White IM; Ciancone MT; Haracz JL; Rebec GV Pharmacol Biochem Behav; 1992 Jan; 41(1):29-35. PubMed ID: 1347175 [TBL] [Abstract][Full Text] [Related]
6. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment. Hu XT; Wang RY Brain Res; 1989 May; 486(2):325-33. PubMed ID: 2786442 [TBL] [Abstract][Full Text] [Related]
8. WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics. Grauer SM; Graf R; Navarra R; Sung A; Logue SF; Stack G; Huselton C; Liu Z; Comery TA; Marquis KL; Rosenzweig-Lipson S Psychopharmacology (Berl); 2009 May; 204(1):37-48. PubMed ID: 19107466 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: comparison with typical and atypical antipsychotics. Britton DR; Curzon P; Yahiro L; Buckley M; Tufano M; Nadzan A Pharmacol Biochem Behav; 1992 Oct; 43(2):369-76. PubMed ID: 1359571 [TBL] [Abstract][Full Text] [Related]
10. Sex differences in the effects of neuroleptics on escape-avoidance behavior in mice: a review. Parra A; Arenas MC; Monleón S; Vinader-Caerols C; Simón VM Pharmacol Biochem Behav; 1999 Dec; 64(4):813-20. PubMed ID: 10593205 [TBL] [Abstract][Full Text] [Related]